$7.13
-0.05-0.70%
At Close: -
$7.13
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
AngioDynamics
ANGONASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
AngioDynamics (NASDAQ:ANGO) Stock, Analyst Ratings, Price Targets, Forecasts
AngioDynamics Inc has a consensus price target of $12.25 based on the ratings of 4 analysts. The high is $14 issued by HC Wainwright & Co. on July 17, 2024. The low is $10 issued by Raymond James on January 9, 2024. The 3 most-recent analyst ratings were released by Canaccord Genuity, HC Wainwright & Co., and HC Wainwright & Co. on July 17, 2024, July 17, 2024, and May 22, 2024, respectively. With an average price target of $13.67 between Canaccord Genuity, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 91.68% upside for AngioDynamics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
HC Wainwright & Co.
Oppenheimer
Raymond James
1calculated from analyst ratings
Analyst Ratings for AngioDynamics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | Buy Now | 82.33% | Canaccord Genuity | William Plovanic | $18 → $13 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | 96.35% | HC Wainwright & Co. | Yi Chen | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2024 | Buy Now | 96.35% | HC Wainwright & Co. | Yi Chen | → $14 | Reiterates | Buy → Buy | Get Alert |
| 04/05/2024 | Buy Now | 68.3% | Oppenheimer | Steven Lichtman | → $12 | Upgrade | Perform → Outperform | Get Alert |
| 01/09/2024 | Buy Now | 40.25% | Raymond James | Jayson Bedford | $12 → $10 | Maintains | Outperform | Get Alert |
| 01/08/2024 | Buy Now | 152.45% | HC Wainwright & Co. | Yi Chen | $20 → $18 | Maintains | Buy | Get Alert |
| 10/06/2023 | Buy Now | 68.3% | Raymond James | Jayson Bedford | $13 → $12 | Maintains | Outperform | Get Alert |
| 10/05/2023 | Buy Now | 138.43% | Canaccord Genuity | William Plovanic | $20 → $17 | Maintains | Buy | Get Alert |
| 10/05/2023 | Buy Now | 180.5% | HC Wainwright & Co. | Yi Chen | $19 → $20 | Maintains | Buy | Get Alert |
| 09/25/2023 | Buy Now | 166.48% | HC Wainwright & Co. | Yi Chen | → $19 | Initiates | → Buy | Get Alert |
| 07/13/2023 | Buy Now | 180.5% | Canaccord Genuity | William Plovanic | $18 → $20 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 82.33% | Raymond James | Jayson Bedford | $14 → $13 | Downgrade | Strong Buy → Outperform | Get Alert |
| 04/03/2023 | Buy Now | 96.35% | Raymond James | Jayson Bedford | $22 → $14 | Maintains | Strong Buy | Get Alert |
| 01/06/2023 | Buy Now | 208.56% | Raymond James | Jayson Bedford | $25 → $22 | Maintains | Strong Buy | Get Alert |
| 10/07/2022 | Buy Now | 250.63% | Raymond James | Jayson Bedford | $27 → $25 | Maintains | Strong Buy | Get Alert |
| 07/13/2022 | Buy Now | 278.68% | Raymond James | Jayson Bedford | $32 → $27 | Maintains | Strong Buy | Get Alert |
| 10/15/2021 | Buy Now | 418.93% | Canaccord Genuity | William Plovanic | — | Upgrade | Hold → Buy | Get Alert |
| 08/20/2021 | Buy Now | — | Oppenheimer | Steven Lichtman | — | Initiates | → Perform | Get Alert |
FAQ
What is the target price for AngioDynamics (ANGO) stock?
The latest price target for AngioDynamics (NASDAQ:ANGO) was reported by Canaccord Genuity on July 17, 2024. The analyst firm set a price target for $13.00 expecting ANGO to rise to within 12 months (a possible 82.33% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AngioDynamics (ANGO)?
The latest analyst rating for AngioDynamics (NASDAQ:ANGO) was provided by Canaccord Genuity, and AngioDynamics maintained their buy rating.
When was the last upgrade for AngioDynamics (ANGO)?
The last upgrade for AngioDynamics Inc happened on April 5, 2024 when Oppenheimer raised their price target to $12. Oppenheimer previously had a perform for AngioDynamics Inc.
When was the last downgrade for AngioDynamics (ANGO)?
The last downgrade for AngioDynamics Inc happened on April 17, 2023 when Raymond James changed their price target from $14 to $13 for AngioDynamics Inc.
When is the next analyst rating going to be posted or updated for AngioDynamics (ANGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AngioDynamics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AngioDynamics was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.
Is the Analyst Rating AngioDynamics (ANGO) correct?
While ratings are subjective and will change, the latest AngioDynamics (ANGO) rating was a maintained with a price target of $18.00 to $13.00. The current price AngioDynamics (ANGO) is trading at is $7.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.